SO
RNAM

STRS Ohio’s Avidity Biosciences RNAM Stock Holding History

STRS Ohio’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-26,000
Closed -$1.88M – 2207
2025
Q4 		$1.88M Buy
26,000
+15,700
+152% +$1.01M 0.01% 588
2025
Q3 		$449K Buy
10,300
+4,700
+84% +$190K ﹤0.01% 1152
2025
Q2 		$159K Sell
5,600
-500
-8% -$14.9K ﹤0.01% 1734
2025
Q1 		$180K Sell
6,100
-5,200
-46% -$162K ﹤0.01% 1540
2024
Q4 		$329K Hold
11,300
– – ﹤0.01% 1350
2024
Q3 		$519K Buy
11,300
+1,300
+13% +$56.4K ﹤0.01% 1243
2024
Q2 		$409K Buy
+10,000
New +$287K ﹤0.01% 1339
2021
Q1 		– Sell
-4,200
Closed -$107K – 2265
2020
Q4 		$107K Hold
4,200
– – ﹤0.01% 1872
2020
Q3 		$118K Buy
+4,200
New +$121K ﹤0.01% 1811

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $158M AUM

STRS Ohio's RNAM Position: Q1 2026 in Review

STRS Ohio sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 26,000 shares — an estimated $1.88M sold.

STRS Ohio first reported a position in RNAM in Q3 2020 and held it in 9 quarters. The position peaked at $1.88M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • STRS Ohio reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • STRS Ohio sold 26,000 Avidity Biosciences shares in Q1 2026, an estimated $1.88M.
  • STRS Ohio first reported a position in Avidity Biosciences in Q3 2020 and held it in 9 quarters.
  • STRS Ohio's Avidity Biosciences position peaked at $1.88M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on STRS Ohio's 13F filing for Q1 2026, filed 24 Apr 2026.